Filtered By:
Specialty: Cardiology
Source: European Heart Journal
This page shows you your search results in order of relevance. This is page number 17.
Order by Relevance | Date
Total 332 results found since Jan 2013.
Specific risk of atrial fibrillation and stroke in oncology patients
Source: European Heart Journal - September 29, 2016 Category: Cardiology Authors: Zamorano, J. L. Tags: CardioPulse Source Type: research
Racing against time in acute ischaemic stroke treatment
Source: European Heart Journal - October 17, 2016 Category: Cardiology Tags: CardioPulse Source Type: research
Sodium-glucose cotransporter-2 inhibition for the reduction of cardiovascular events in high-risk patients with diabetes mellitus
Patients with type 2 diabetes mellitus (T2D) exhibit an increased risk for cardiovascular (CV) events. Hyperglycaemia itself contributes to the pathogenesis of atherosclerosis and heart failure (HF) in these patients, but glucose-lowering strategies studied to date have had little to no impact on reducing CV risk, especially in patients with a long duration of T2D and prevalent CV disease (CVD). Sodium glucose cotransporter-2 (SGLT2) inhibitors are a novel class of anti-hyperglycaemic medications that increase urinary glucose excretion, thus improving glycaemic control independent of insulin. The recently published CV outc...
Source: European Heart Journal - November 16, 2016 Category: Cardiology Authors: Marx, N., McGuire, D. K. Tags: Clinical update Source Type: research
The search for the ideal atrial fibrillation stroke risk prediction schema: is ATRIA a contender?
Source: European Heart Journal - November 16, 2016 Category: Cardiology Authors: Cairns, J. A. Tags: Editorial Source Type: research
Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction
Conclusions
In addition to limited LV reserve, patients with HFpEF display impaired RV reserve during exercise that is associated with high filling pressures and inadequate CO responses. These findings highlight the importance of biventricular dysfunction in HFpEF and suggest that novel therapies targeting myocardial reserve in both the left and right heart may be effective to improve clinical status.
Source: European Heart Journal - December 8, 2016 Category: Cardiology Authors: Borlaug, B. A., Kane, G. C., Melenovsky, V., Olson, T. P. Tags: Heart failure/cardiomyopathy Source Type: research
The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial
Conclusion
The clinical benefit of adding ezetimibe to statin appears to be enhanced in patients with prior CABG, supporting the use of intensive lipid lowering therapy in these high-risk patients following ACS.
Source: European Heart Journal - January 12, 2017 Category: Cardiology Authors: Eisen, A., Cannon, C. P., Blazing, M. A., Bohula, E. A., Park, J.-G., Murphy, S. A., White, J. A., Giugliano, R. P., Braunwald, E., on behalf of the IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial) Investigators Tags: Acute coronary syndromes Source Type: research
Stroke prevention in Atrial Fibrillation
Source: European Heart Journal - January 20, 2017 Category: Cardiology Authors: Lip, G. Y. H. Tags: CardioPulse Source Type: research
A frameshift deletion in the sarcomere gene MYL4 causes early-onset familial atrial fibrillation
Conclusions</div>Through a population approach we found a loss of function mutation in the myosin gene <span style="font-style:italic;">MYL4</span> that, in the homozygous state, is completely penetrant for early-onset AF. The finding may provide novel mechanistic insight into the pathophysiology of this complex arrhythmia.</span>
Source: European Heart Journal - October 13, 2016 Category: Cardiology Source Type: research
Persistent stem cell-driven inflammation in patients with prior MI and stroke
<span class="paragraphSection"><strong><a href="article.aspx?volume=&page="><strong>This editorial refers to ‘Increased haematopoietic activity in patients with atherosclerosis’†<sup>†</sup>, by F.M. van der Valk <span style="font-style:italic;">et al</span>., on page 425.</strong><span></span></a></strong></span>
Source: European Heart Journal - July 27, 2016 Category: Cardiology Source Type: research
Coronary microcirculatory pathophysiology: can we afford it to remain a black box?
<span class="paragraphSection"><div class="boxTitle">Abstract</div>Coronary microvascular networks play the key role in determining blood flow distribution in the heart. Matching local blood supply to tissue metabolic demand entails continuous adaptation of coronary vessels via regulation of smooth muscle tone and structural dilated vessel diameter. The importance of coronary microcirculation for relevant pathological conditions including angina in patients with normal or near-normal coronary angiograms [microvascular angina (MVA)] and heart failure with preserved ejection fraction (HFpEF) is increasingly...
Source: European Heart Journal - February 1, 2016 Category: Cardiology Source Type: research
The European Society of Cardiology Stroke Council
<span class="paragraphSection"><strong>A new ‘ESC baby’ is growing up quickly, reports Petr Widimsky</strong> </span>
Source: European Heart Journal - February 27, 2017 Category: Cardiology Source Type: research
Frontiers in heart failure: sodium, longitudinal strain, contractility sensor, fatal arrhythmias, and stroke
<span class="paragraphSection"></span>
Source: European Heart Journal - March 9, 2017 Category: Cardiology Source Type: research
Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors
Conclusion</div>Plasma TMAO levels among patients presenting with chest pain predict both near- and long-term risks of incident cardiovascular events, and may thus provide clinical utility in risk stratification among subjects presenting with suspected ACS.</span>
Source: European Heart Journal - January 10, 2017 Category: Cardiology Source Type: research
Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the EROSION study)
Conclusion</div>For patients with ACS caused by plaque erosion, conservative treatment with anti-thrombotic therapy without stenting may be an option.</span>
Source: European Heart Journal - August 29, 2016 Category: Cardiology Source Type: research